ClinConnect ClinConnect Logo
Search / Trial NCT06835920

Alcohol Labeling Study

Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Feb 14, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The Alcohol Labeling Study is looking at how new health warnings on alcohol containers might affect how much people drink. In this study, participants will be randomly placed into two groups: one will see the new health warnings on their alcohol, while the other group will see standard labels. Participants will bring their own alcohol to the study visits and consume it as they usually would at home.

To join this study, you need to be at least 21 years old, drink alcohol at least once a week, and not have any issues with alcohol dependence. You'll also need to be able to attend three in-person visits and bring enough alcohol for those visits. Additionally, you should be comfortable taking surveys in English and responding to daily text messages for three weeks. This study is not yet recruiting, and it is important to note that only people living in the U.S. can participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults ages 21 years and older
  • Not identified as having possible alcohol dependence
  • Consumed alcohol at least once per week during the past 4 weeks
  • At least half of alcohol consumed each week is from store-bought containers
  • Willing to bring 8 days' worth of alcohol to 3 in-person study visits
  • Not pregnant, breastfeeding, or trying to get pregnant
  • Able to take surveys in English
  • Willing to respond to text messages daily for 3 weeks
  • Not living in the same household as anyone else in the study
  • Exclusion Criteria:
  • - Not living in US

About University Of North Carolina, Chapel Hill

The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.

Locations

Chapel Hill, North Carolina, United States

Chapel Hill, North Carolina, United States

Chapel Hill, North Carolina, United States

Patients applied

0 patients applied

Trial Officials

Marissa Hall, PhD

Principal Investigator

University of North Carolina, Chapel Hill

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported